Aviation Medication Transparency Act of 2025
- Last Action
- 11/20/2025
Actions
- 2026-09-14Placed on Senate Legislative Calendar under General Orders. Calendar No. 559.
- 2026-09-14Committee on Commerce, Science, and Transportation. Reported by Senator Cruz with an amendment in the nature of a substitute. With written report No. 119-140.
- 2026-09-14Committee on Commerce, Science, and Transportation. Reported by Senator Cruz with an amendment in the nature of a substitute. With written report No. 119-140.
- 2026-07-22Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
- 2025-11-20Read twice and referred to the Committee on Commerce, Science, and Transportation.
- 2025-11-20Introduced in Senate
CRS Summary
As of 2025-11-20 (00)
Aviation Medication Transparency Act of 2025
This bill directs the Federal Aviation Administration (FAA) to compile, publish, and annually update a list of medications that may be safely prescribed to pilots and air traffic controllers for the purposes of issuing a medical certification. The list must be publicly available on the FAA website and distributed to those seeking a license and medical certification.
Currently, the FAA does not have a list of approved medications. However, the FAA does have lists for Aviation Medical Examiners of Do Not Issue medications and Do Not Fly medications.
Cosponsors (5)
- John Hoeven (R-ND)
- Richard Durbin (D-IL)
- Katie Britt (R-AL)
- John Hickenlooper (D-CO)
- James Risch (R-ID)
Subjects
- Aviation and airports
- Government information and archives
- Licensing and registrations
- Prescription drugs
- Transportation employees
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.